Dr Alexander Lyon, Consultant Cardiologist
Dr Alexander Lyon
Consultant Cardiologist
Dr Alexander Lyon MA BM BCh PhD FRCP FHFA
Consultant Cardiologist
Dr Alexander Lyon
Consultant Cardiologist MA BM BCh PhD FRCP FHFA
Dr Lyon is a recommended Consultant Cardiologist
Areas of expertise
- Heart failure
- Cardiovascular diseases caused by cancer treatments
- Chemotherapy-induced heart failure
- Takotsubo syndrome
Recommendations for Dr Lyon
These recommendations are for information purposes only. Doctors providing recommendations do so in good faith and are not responsible for clinical outcomes.
Recommended by:
byDr Paul Glynne, General (Internal) Medicine
❝Dr Alex Lyon is an accomplished academic heart failure specialist with an interest in drug-induced cardiomyopathy.❞
byProf. Anthony Warrens, Consultant Renal Physician
❝I've worked very closely with Dr Alex Lyon and he's an excellent physician. I would recommend him.❞
by Dr Gavin Johnson, Gastroenterologist
❝Top of his game and excellent patient feedback❞
byDr Paul Glynne, General (Internal) Medicine
❝Dr Alex Lyon is an accomplished academic heart failure specialist with an interest in drug-induced cardiomyopathy.❞
byProf. Anthony Warrens, Consultant Renal Physician
❝I've worked very closely with Dr Alex Lyon and he's an excellent physician. I would recommend him.❞
by Dr Gavin Johnson, Gastroenterologist
❝Top of his game and excellent patient feedback❞
Make an appointment
Address
-
The Harley Street Clinic
35 Weymouth Street, London, W1G 8BJ
-
The Physicians' Clinic
14 Devonshire St, London, W1G 7AE
About Dr Alexander Lyon
GMC number: 4530330
Year qualified: 1998
Place of primary qualification: Oxford University
Dr Alexander Lyon is a highly esteemed consultant cardiologist and senior lecturer at Royal Brompton Hospital, appointed in 2012. He specialises in heart failure, cardio-oncology, and Takotsubo syndrome. Dr Lyon's clinical expertise extends to chemotherapy-induced heart failure, cardiac gene therapy, and novel molecular and biological therapies for heart failure. He runs a specialist clinic for patients with Takotsubo syndrome, focusing on risk prediction and management of refractory symptoms.
Dr Lyon serves as the clinical lead for the cardio-oncology service at Royal Brompton Hospital since 2011 and chairs the UK Cardio-Oncology Consortium from 2012. He is also a member of the Heart Failure Association Translational Research Committee of the European Society of Cardiology since 2012. His interests include the impact of cancer treatments on cardiovascular health and the development of innovative therapies for heart failure.
Dr Lyon treats a range of conditions including hypertension, heart valve disease, coronary artery disease, cardiomyopathy, and chest pain. He also provides general cardiac health checks to guide risk factor management. His dedication to advancing cardiology is evident through his numerous awards, including the Bernard and Joan Marshall Young Investigator Prize from the British Society for Cardiovascular Research in 2010.
Areas of expertise
- Arrhythmia (irregular heartbeat)
- High blood pressure
- Atrial fibrillation
- Heart attack
- Angina
- Atherosclerosis
- Bradycardia
- Cardiomyopathy
- Chest pain
- Congestive heart failure
- Coronary artery disease
- Dizziness
- Heart failure
- Heart murmurs
- Heart muscle disease
- Heart valve problems
- Hypertrophic cardiomyopathy
- Low blood pressure
- Palpitations
- Pulmonary hypertension
- Tachycardia
- Valvular heart disease
Professional memberships
Articles by Dr Alexander Lyon
Risk stratification and management of women with cardiomyopathy/heart failure planning pregnancy or presenting during/after pregnancy
Impact of coronavirus disease 2019 (covid-19) outbreak on acute admissions at the emergency and cardiology departments across europe
The prevalence of iron deficiency and anemia and their impact on survival in patients at a cardio-oncology clinic
Risk of cardiovascular diseases among older breast cancer survivors in the united states: a matched cohort study
Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the cardiotox registry
Cardiovascular disease following breast cancer treatment: can we predict who will be affected?
Prevention, detection, and management of heart failure in patients treated for breast cancer
Endocrine therapy use and cardiovascular risk in postmenopausal breast cancer survivors
Pathophysiology of takotsubo syndrome: jacc state-of-the-art review
